News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
146 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17605)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
1 (158)
2 (163)
3 (102)
6 (153)
7 (152)
8 (152)
9 (194)
10 (107)
13 (153)
14 (175)
15 (179)
16 (162)
17 (120)
18 (1)
20 (146)
21 (192)
22 (191)
23 (193)
24 (168)
27 (205)
28 (277)
29 (183)
30 (208)
31 (154)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
6
7
8
9
10
13
14
15
16
17
18
20
21
22
23
24
27
28
29
30
31
BioForest
Cell Therapeutics, Inc. High-Dose Zevalin(R) With Tandem Stem Cell Infusion Produces 87 Percent Overall Survival in Relapsed/Refractory or High Risk Non-Hodgkin’s Lymphoma
October 20, 2008
·
6 min read
Drug Development
Depomed, Inc. Initiates Second Phase 3 Trial in Menopausal Hot Flashes
October 20, 2008
·
1 min read
Drug Development
GeoVax Labs Inc.'s DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
October 20, 2008
·
4 min read
Biotech Beach
Advanced Medical Optics, Inc. Announces Note Purchase
October 20, 2008
·
1 min read
BioForest
Response Biomedical Announces $5.5 Million Financing Terms Amended
October 20, 2008
·
5 min read
FDA
Cardium Therapeutics, Inc. Announces FDA 510(K) Clearance of InnerCool’s RapidBlue(TM) Endovascular System
October 20, 2008
·
15 min read
Drug Development
Elan Diagnostics, Inc. (“EDx”) and Transition Therapeutics Inc. Achieve Patient Enrollment Target in Phase 2 Clinical Study of ELND005 (AZD-103) in Alzheimer’s Disease
October 20, 2008
·
1 min read
Policy
TaiGen Biotechnology Announces Presentation of Nemonoxacin at the Joint Meeting of ICAAC/IDSA
October 20, 2008
·
1 min read
BNC Collaborators Author High-profile Paper in Nature Nanotechnology
October 20, 2008
·
3 min read
Policy
Forest Laboratories, Inc. (JOBS), Cypress Bioscience Inc. Fibromyalgia Drug Delayed at FDA
October 20, 2008
·
3 min read
Previous
9 of 15
Next